0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Internal Medicine | 
Research Letter |  ONLINE FIRST
Matthew J. Maurice, MD; Robert Abouassaly, MD, MS; Simon P. Kim, MD, MPH; et al.
JAMA Intern Med. Published online June 29, 2015. doi:10.1001/jamainternmed.2015.2835

JAMA Oncology | 
Editorial |  FREE ONLINE FIRST
Mary-Ellen Taplin, MD; Steven P. Balk, MD, PhD
JAMA Oncol. Published online June 04, 2015. doi:10.1001/jamaoncol.2015.1457

JAMA Oncology | 
From The JAMA Network |  ONLINE FIRST
Bertrand F. Tombal, MD, PhD; Sandy Van Nieuwenhove, MD; Frederic E. Lecouvet, MD, PhD
JAMA Oncol. Published online June 04, 2015. doi:10.1001/jamaoncol.2015.1063

JAMA Oncology | 
Original Investigation |  FREE ONLINE FIRST
Emmanuel S. Antonarakis, MD; Changxue Lu, PhD; Brandon Luber, ScM; et al.
JAMA Oncol. Published online June 04, 2015. doi:10.1001/jamaoncol.2015.1341
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  FREE
Ann C. Raldow, MD; Danjie Zhang, PhD; Ming-Hui Chen, PhD; et al.
JAMA Oncol. 2015;1(3):334-340. doi:10.1001/jamaoncol.2014.284.

JAMA Oncology | 
Invited Commentary |  FREE
William D. Figg, PharmD, MBA; Ian M. Thompson, MD
JAMA Oncol. 2015;1(3):321-322. doi:10.1001/jamaoncol.2015.0408.

JAMA Oncology | 
Original Investigation |  FREE
Laurent Azoulay, PhD; Maria Eberg, MSc; Serge Benayoun, MD, MSc; et al.
JAMA Oncol. 2015;1(3):314-320. doi:10.1001/jamaoncol.2015.0387.
Includes: Supplemental Content

JAMA Oncology | 
Editor's Note |  FREE
Charles R. Thomas Jr, MD
JAMA Oncol. 2015;1(3):349. doi:10.1001/jamaoncol.2015.0514.

JAMA Oncology | 
Original Investigation |  FREE
Wendy E. Barrington, PhD; Jeannette M. Schenk, PhD; Ruth Etzioni, PhD; et al.
JAMA Oncol. 2015;1(3):342-349. doi:10.1001/jamaoncol.2015.0513.
Includes: Supplemental Content

JAMA Oncology | 
Invited Commentary |  FREE
Fred Saad, MD
JAMA Oncol. 2015;1(3):340-341. doi:10.1001/jamaoncol.2015.103.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Internal Medicine
Research Letter  | 
Contemporary Nationwide Patterns of Active Surveillance Use for Prostate Cancer
Matthew J. Maurice, MD; Robert Abouassaly, MD, MS; Simon P. Kim, MD, MPH; et al.
JAMA Oncology
Editorial  | 
Has the Time Arrived for Biomarker-Directed Therapy in Castration-Resistant Prostate Cancer?
Mary-Ellen Taplin, MD; Steven P. Balk, MD, PhD
JAMA Oncology
From The JAMA Network  | 
Prostate Cancer Diagnosis Using MR/Ultrasound–Fusion Guided Biopsy:  Ending the “Needle in a Haystack” Conundrum?
Bertrand F. Tombal, MD, PhD; Sandy Van Nieuwenhove, MD; Frederic E. Lecouvet, MD, PhD
JAMA Oncology
Original Investigation  | 
Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
Emmanuel S. Antonarakis, MD; Changxue Lu, PhD; Brandon Luber, ScM; et al.